MICHAEL KASETA
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
DIRECTOR
PHILIP ASHMAN, GLEN BRADLEY, MARK BROOKS, SUSAN CABALLA, RICHARD EISWIRTH, RICHARD S. EISWIRTH, RICHARD S. EISWIRTH, JR., KENNETH GREEN, BRIAN HALAK, BRIAN K. HALAK, DAVID HOLLAND, ANDERS HOVE, J. PHILIP JONES, GARHENG KONG, JAMES R. LARGENT, ADAM MORGAN, C. DANIEL MYERS, CHARLES DANIEL MYERS, DANIEL MYERS, ERIN PARSONS, PETER J. PIZZO, PETER J. PIZZO III, CALVIN ROBERTS, CALVIN W. ROBERTS, ROGER SAWHENY, RUSSELL SKIBSTED, JOHN SNISARENKO, MARY T. SZELA, PHIL TRACY, PHILIP TRACY, BRYCE YOUNGREN
DIRECTOR
STEPHEN BECKMAN, JAMES BORNEMAN, JIM BORNEMAN, DAVID DWORACZYK, KATE GRELL, KATHERINE GRELL, STEVEN HARTMAN, JEFF HARTNESS, WILLIAM HUMPHRIES, STEVE KILLMEYER, STEVEN KILLMEYER, LISA LICHT, MICHELLE LOBEL, SANDRA LOREAUX, SANDY LOREAUX, MARC RAPAPORT, DALE SANDER, RICK SCHADEN, KATE SOPER DIAZ, ANNE WHITAKER, ROBERT YANEZ, JOSHUA ZIEL
DIRECTOR
STEPHEN BECKMAN, JAMES BORNEMAN, JIM BORNEMAN, DAVID DWORACZYK, KATE GRELL, KATHERINE GRELL, STEVEN HARTMAN, JEFF HARTNESS, WILLIAM HUMPHRIES, STEVE KILLMEYER, STEVEN KILLMEYER, LISA LICHT, MICHELLE LOBEL, SANDRA LOREAUX, SANDY LOREAUX, MARC RAPAPORT, DALE SANDER, RICK SCHADEN, KATE SOPER DIAZ, ANNE WHITAKER, ROBERT YANEZ, JOSHUA ZIEL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2023-03-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-04-13

